| scholarly article | Q13442814 |
| P50 | author | Hani El-Gabalawy | Q61799263 |
| Erika Darrah | Q59549445 | ||
| P2093 | author name string | Marvin J Fritzler | |
| Antony Rosen | |||
| Elizabeth D Ferucci | |||
| Marianna M Newkirk | |||
| David B Robinson | |||
| Tammy L Choromanski | |||
| Irene Smolik | |||
| P2860 | cites work | Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes | Q59922398 |
| Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations | Q71657474 | ||
| Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity | Q79843008 | ||
| Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis | Q81045791 | ||
| Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents | Q81820607 | ||
| Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis | Q83140472 | ||
| Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis | Q84598175 | ||
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| Association between PADI4 and rheumatoid arthritis: a replication study | Q28275244 | ||
| Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? | Q34027435 | ||
| Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis | Q34137749 | ||
| Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. | Q34159040 | ||
| Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. | Q34166023 | ||
| Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis | Q34290839 | ||
| N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. | Q34904630 | ||
| Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions | Q34953349 | ||
| Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis | Q35825742 | ||
| Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature | Q36031009 | ||
| Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis | Q37142137 | ||
| Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. | Q37217463 | ||
| Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease | Q37628193 | ||
| Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis. | Q37724560 | ||
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
| Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. | Q43205841 | ||
| Arthritis in Aboriginal Manitobans: evidence for a high burden of disease. | Q44017768 | ||
| Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis | Q44616885 | ||
| Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study | Q44800314 | ||
| Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis | Q46680324 | ||
| Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation | Q46925018 | ||
| Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives | Q47893696 | ||
| Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease | Q58234911 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 1523-1528 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations | |
| P478 | volume | 40 |
| Q37358849 | Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans |
| Q36176344 | Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins. |
| Q50193229 | Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis |
| Q38628324 | Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. |
| Q93270547 | PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets |
| Q27003201 | Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE |
| Q37063571 | Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study |
| Q86301346 | Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases |
| Q55257092 | Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis. |
| Q35832816 | Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study |
| Q36366153 | Strategies to predict rheumatoid arthritis development in at-risk populations |
| Q37709963 | Systematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand. |
| Q38206946 | The pathogenic potential of autoreactive antibodies in rheumatoid arthritis. |
Search more.